Christian R. Andres

Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection

P. Corcia, H. Blasco, F. Patin, 2016, Expert opinion on pharmacotherapy.

The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism

L. Plantier, P. Vourc'h, C. Andres, 2020, Scientific Reports.

Further development of biomarkers in amyotrophic lateral sclerosis

P. Vourc'h, P. Corcia, P. Gordon, 2016, Expert review of molecular diagnostics.

Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection

P. Corcia, H. Blasco, F. Patin, 2016, Expert opinion on pharmacotherapy.

Roles of LIM kinases in central nervous system function and dysfunction

P. Vourc'h, B. Vallée, H. Bénédetti, 2015, FEBS letters.

Post-Translational Variants of Major Proteins in Amyotrophic Lateral Sclerosis Provide New Insights into the Pathophysiology of the Disease

P. Vourc'h, P. Corcia, S. Marouillat, 2024, International journal of molecular sciences.

N-Terminal Fragments of TDP-43—In Vitro Analysis and Implication in the Pathophysiology of Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration

P. Vourc'h, P. Corcia, S. Marouillat, 2024, Genes.

Biological follow‐up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis

P. Vourc'h, P. Corcia, C. Veyrat-Durebex, 2015, European journal of neurology.